Literature DB >> 11716951

Modelling constant potential amperometry for investigations of dopaminergic neurotransmission kinetics in vivo.

D Schönfuss1, T Reum, P Olshausen, T Fischer, R Morgenstern.   

Abstract

Constant potential amperometry (CPA) was used for in vivo recording of extracellular dopamine (DA) after electrical stimulation of the medial forebrain bundle (MFB) (4 pulses, 2 mA, 20 or 100 Hz) in the striatum of the rat brain. CPA signals were analysed in the absence and presence of the DA uptake inhibitor nomifensine with the help of a mathematical model which considered both the influence of DA diffusion after its stimulated release and the Michaelis-Menten kinetics of cellular DA uptake from the extracellular space. We found an excellent conformity of experimentally obtained CPA signals and calculated curves. Mathematical analysis revealed that CPA signals were strongly influenced by DA diffusion. The kinetic parameters calculated from CPA signals in this study were in agreement with experimental determinations of Vmax and Km of extracellular DA uptake in other studies and reflect the particular pharmacological properties of nomifensine. CPA is a useful and efficient method for in vivo estimation of individual changes of DA kinetic parameters by pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716951     DOI: 10.1016/s0165-0270(01)00465-4

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  Droplet-based microdialysis-Concept, theory, and design considerations.

Authors:  Cheng-Fu Chen; Kelly L Drew
Journal:  J Chromatogr A       Date:  2008-09-07       Impact factor: 4.759

2.  Genotype-dependent effects of adolescent nicotine exposure on dopamine functional dynamics in the nucleus accumbens shell in male and female mice: a potential mechanism underlying the gateway effect of nicotine.

Authors:  Price E Dickson; Tiffany D Rogers; Deranda B Lester; Mellessa M Miller; Shannon G Matta; Elissa J Chesler; Dan Goldowitz; Charles D Blaha; Guy Mittleman
Journal:  Psychopharmacology (Berl)       Date:  2011-01-07       Impact factor: 4.530

3.  In Vitro Electrochemistry of Biological Systems.

Authors:  Kelly L Adams; Maja Puchades; Andrew G Ewing
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2008-07-01       Impact factor: 10.745

4.  Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S.

Authors:  Xianting Li; Jyoti C Patel; Jing Wang; Marat V Avshalumov; Charles Nicholson; Joseph D Buxbaum; Gregory A Elder; Margaret E Rice; Zhenyu Yue
Journal:  J Neurosci       Date:  2010-02-03       Impact factor: 6.167

5.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Vivienne A Russell; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropharmacology       Date:  2012-09-01       Impact factor: 5.250

6.  Stimulation-evoked dopamine release in the nucleus accumbens following cocaine administration in rats perinatally exposed to polychlorinated biphenyls.

Authors:  Jenna R Fielding; Tiffany D Rogers; Abby E Meyer; Mellessa M Miller; Jenna L Nelms; Guy Mittleman; Charles D Blaha; Helen J K Sable
Journal:  Toxicol Sci       Date:  2013-08-02       Impact factor: 4.849

7.  Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake.

Authors:  Kathrine L Jensen; Annika H Runegaard; Pia Weikop; Ulrik Gether; Mattias Rickhag
Journal:  J Vis Exp       Date:  2017-09-21       Impact factor: 1.355

8.  A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learning.

Authors:  Florence Véronneau-Veilleux; Philippe Robaey; Mauro Ursino; Fahima Nekka
Journal:  Front Comput Neurosci       Date:  2022-07-18       Impact factor: 3.387

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.